>>Signaling Pathways>> Chromatin/Epigenetics>> Epigenetic Reader Domain>>I-BET 151 dihydrochloride

I-BET 151 dihydrochloride (Synonyms: GSK1210151A dihydrochloride)

Catalog No.GC50070

I-BET 151 디히드로클로라이드(GSK1210151A 디히드로클로라이드)는 각각 6.1, 6.3 및 6.6의 pIC50으로 BRD4, BRD2 및 BRD3을 억제하는 BET 브로모도메인 억제제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

I-BET 151 dihydrochloride Chemical Structure

Cas No.: 1883545-47-8

Size 가격 재고 수량
10 mg
US$397.00
재고 있음
50 mg
US$1,626.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BET bromodomain inhibitor; blocks recruitment of BET to chromatin. Induces apoptosis and G0/G1 cell cycle arrest in MLL-fusion leukemic cell lines in vitro (IC50 values are 15, 26, 120 and 192 nM for NOMO1, MV4;11, MOLM13 and RS4;11 cell lines respectively); reduces BCL2 expression in NOMO1 cells. Improves survival in two rodent models of MLL-fusion leukemia in vivo. Enhances differentiation of human iPSC into megakaryocytes. Also enhances fibroblast reprogramming to hiPSCs at low concentration.

Dawson et al (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478 529 PMID:21964340 |Feng et al (2014) Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports 3 817 PMID:25418726 |Shao et al (2016) Reprogramming by de-bookmarking the somatic transcriptional program through targeting of BET bromodomains. Cell Rep. 16 3138 PMID:27653680

리뷰

Review for I-BET 151 dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for I-BET 151 dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.